Please contact us for more information or to learn if you are eligible to participate.
This phase II/III trial studies how well circulating tumor deoxyribonucleic acid (ctDNA) testing in the blood works in predicting treatment for patients with stage IIA colon cancer after surgery.
Principal Investigator | Dr. Jose Cruz |
Co-PI | Edgar Lopez Pacheco |
Sponsor | National Cancer Institute (NCI) |
Type of Trial | Interventional |